Physician profile
William Wells
NPI 1194799965
$658,826.13
in general payments reported to CMS, 2019-2025
15 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282K · 2020: $86K · 2021: $138K · 2022: $133K · 2023: $20K · 2024: $389 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $1,998 · Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,250.00 |
| Travel and Lodging | $1,997.79 |
| Food and Beverage | $1,144.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $657,926.95 | 2019-2024 | Xpress Ent Dilation System, Latera, Scopis Ent |
| Optinose US, INC. | $228.89 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $185.83 | 2020-2024 | Dupixent |
| Intersect Ent, INC. | $120.41 | 2020-2022 | |
| Kaleo, INC. | $72.55 | 2019-2021 | |
| Biocryst US Sales Co., LLC | $60.58 | 2024 | Orladeyo |
| Genzyme Corporation | $48.28 | 2022-2025 | |
| Glaxosmithkline, LLC. | $42.07 | 2025 | Nucala |
| Genentech USA, INC. | $30.51 | 2025 | Xolair |
| Novartis Pharmaceuticals Corporation | $25.06 | 2024 | |
| Acclarent, INC | $20.78 | 2020 | |
| Medtronic, INC. | $19.09 | 2023 | Stealthstation S8 Platform |
| Aerin Medical INC. | $18.25 | 2022 | |
| Hikma Pharmaceuticals USA | $13.58 | 2023 | Ryaltris |
| Merck Sharp & Dohme LLC | $13.30 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.